Literature DB >> 26053309

Abnormal Intrinsic Brain Activity Patterns in Patients with End-Stage Renal Disease Undergoing Peritoneal Dialysis: A Resting-State Functional MR Imaging Study.

Song Luo1, Rong Feng Qi1, Ji Qiu Wen1, Jian Hui Zhong1, Xiang Kong1, Xue Liang1, Qiang Xu1, Gang Zheng1, Zhe Zhang1, Long Jiang Zhang1, Guang Ming Lu1.   

Abstract

PURPOSE: To analyze the spontaneous brain activity patterns in patients with end-stage renal disease (ESRD) undergoing peritoneal dialysis (PD) by using resting-state functional magnetic resonance (MR) imaging with an amplitude of low-frequency fluctuations (ALFF) algorithm.
MATERIALS AND METHODS: This study received institutional review board approval, and all subjects gave informed consent. Forty-four patients with ESRD, 24 of whom were undergoing PD (PD group; eight women; mean age, 34 years ± 8) and 20 who were not undergoing PD or hemodialysis (nondialysis group; six women; mean age, 37 years ± 9) and 24 healthy control subjects (eight women; mean age, 32 years ± 9 years) were included. All subjects underwent neuropsychologic tests, and patients with ESRD underwent laboratory testing. ALFF values were compared among the three groups. The relationship between ALFF values and clinical markers was investigated by using multiple regression analysis.
RESULTS: Patients in both the PD and nondialysis groups showed lower ALFF values in default mode network regions than did healthy control subjects (P < .01, false discovery rate corrected). Patients in the PD group showed lower ALFF values than did those in the nondialysis group in the left superior parietal lobe (1.51 ± 0.21 vs 2.01 ± 0.40), left inferior parietal lobe (0.99 ± 0.16 vs 1.13 ± 0.22) and left precuneus (1.45 ± 0.39 vs 1.77 ± 0.41) (P < .01, corrected with simulation software). In patients in the PD group, neuropsychologic test scores correlated with ALFF values of the middle temporal gyrus and the parietal and occipital lobe, serum urea and creatinine levels negatively correlated with ALFF in some default mode network regions, and hemoglobin positively correlated with ALFF in the bilateral precuneus, precentral, and supplementary motor areas (P < .01 corrected).
CONCLUSION: Patients with ESRD who were undergoing PD showed more severe spontaneous brain activity abnormalities that correlate with cognitive impairments than did patients who were not undergoing dialysis. Elevated serum urea, creatinine, and lowered hemoglobin levels affect spontaneous brain activity in patients with ESRD. © RSNA, 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26053309     DOI: 10.1148/radiol.2015141913

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  29 in total

Review 1.  PET/MRI of central nervous system: current status and future perspective.

Authors:  Zhen Lu Yang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2016-01-15       Impact factor: 5.315

2.  Immediate Abnormal Intrinsic Brain Activity Patterns in Patients with End-stage Renal Disease During a Single Dialysis Session : Resting-state Functional MRI Study.

Authors:  Cong Peng; Hua Yang; Qian Ran; Ling Zhang; Chengxuan Liu; Yu Fang; Yingjiang Liu; Yi Cao; Renrong Liang; He Ren; Qinqin Hu; Xiuting Mei; Yang Jiang; Tianyou Luo
Journal:  Clin Neuroradiol       Date:  2020-07-03       Impact factor: 3.649

3.  Cerebral blood flow changes in hemodialysis and peritoneal dialysis patients: an arterial-spin labeling MR imaging.

Authors:  Xiao Lu Jiang; Ji Qiu Wen; Long Jiang Zhang; Gang Zheng; Xue Li; Zhe Zhang; Ya Liu; Li Juan Zheng; Long Wu; Hui Juan Chen; Xiang Kong; Song Luo; Guang Ming Lu; Xue Man Ji; Zong Jun Zhang
Journal:  Metab Brain Dis       Date:  2016-05-11       Impact factor: 3.584

4.  Deteriorated functional and structural brain networks and normally appearing functional-structural coupling in diabetic kidney disease: a graph theory-based magnetic resonance imaging study.

Authors:  Yun Fei Wang; Ping Gu; Jiong Zhang; Rongfeng Qi; Michael de Veer; Gang Zheng; Qiang Xu; Ya Liu; Guang Ming Lu; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

5.  Altered white matter microstructure mediates the relationship between hemoglobin levels and cognitive control deficits in end-stage renal disease patients.

Authors:  Junya Mu; Tao Chen; Peng Li; Dun Ding; Xueying Ma; Ming Zhang; Jixin Liu
Journal:  Hum Brain Mapp       Date:  2018-07-31       Impact factor: 5.038

6.  The impact of hemodialysis on cognitive dysfunction in patients with end-stage renal disease: a resting-state functional MRI study.

Authors:  Hui Juan Chen; Rongfeng Qi; Xiang Kong; Jiqiu Wen; Xue Liang; Zhe Zhang; Xue Li; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-07-07       Impact factor: 3.584

7.  Advances in dialysis encephalopathy research: a review.

Authors:  Ying Chen; Xin Tian; Xuefeng Wang
Journal:  Neurol Sci       Date:  2018-05-02       Impact factor: 3.307

8.  Elevated global cerebral blood flow, oxygen extraction fraction and unchanged metabolic rate of oxygen in young adults with end-stage renal disease: an MRI study.

Authors:  Gang Zheng; Jiqiu Wen; Hanzhang Lu; Yaxian Lou; Zhiying Pan; Wei Liu; Hui Liu; Xue Li; Zhe Zhang; Huijuan Chen; Xiang Kong; Song Luo; Xiaolu Jiang; Ya Liu; Zongjun Zhang; Long Jiang Zhang; Guang Ming Lu
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

9.  Altered Amygdala Resting-State Functional Connectivity in Maintenance Hemodialysis End-Stage Renal Disease Patients with Depressive Mood.

Authors:  Hui Juan Chen; Yun Fei Wang; Rongfeng Qi; U Joseph Schoepf; Akos Varga-Szemes; B Devon Ball; Zhe Zhang; Xiang Kong; Jiqiu Wen; Xue Li; Guang Ming Lu; Long Jiang Zhang
Journal:  Mol Neurobiol       Date:  2016-03-03       Impact factor: 5.590

10.  Neurovascular coupling dysfunction in end-stage renal disease patients related to cognitive impairment.

Authors:  Peng Li; Junya Mu; Xueying Ma; Dun Ding; Shaohui Ma; Huawen Zhang; Jixin Liu; Ming Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2021-04-14       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.